📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
32
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
29%
🔁 Convertible Conversion
40%
• Significant convertible debt: 21% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split
30%
• 50-day avg $1.07 approaching $1 threshold
💹 Market Data
Market Cap$17.93M
Shares Outstanding17.41M
Float11.42M
Cash$4.59M
Debt$4.28M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 1.6% shares (2025Q4 vs prior)
22 institutional holders · 2.79M shares
#1
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
1.00M shares
#2
VANGUARD GROUP INC
578.7K shares
#3
RENAISSANCE TECHNOLOGIES LLC
371.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest56.5K
Days to Cover1.0
% of Float0.5%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Apr 04, 2026
xbrl
XBRL WARRANT
Aug 31, 2007
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Mar 09, 2026
4
INSIDER TRANSACTION
Feb 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for IRIX
📊 IRIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 IRIX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.